Answers are grounded in this paper and cite their sources.
Indigenous ethnomedicinal knowledge continues to play an important role in community healthcare and cultural traditions, yet it is increasingly vulnerable to erosion and has rarely been quantified for the Suku Anak Dalam (SAD). This study documented medicinal plant use among Suku Anak Dalam (SAD) in Nebang Parah and Nyogan Hamlets, Jambi, Indonesia, and quantified it using reproducible ethnobotanical indices. Data were collected from May to July 2025 through semi-structured interviews, participant observation and voucher-specimen collection involving 100 informants (66 Nyogan, 34 Nebang Parah; 53 men, 47 women; five key and 95 general informants,), yielding 363 plant-part use-reports. Twenty-seven species from 22 families were recorded. Eight preparation methods and seven administration routes were documented, with decoction (12 of 27 taxa) and oral administration (13 of 27 taxa) most frequent. Leaves were the most-used part (PPV = 35.81%), then fruit (19.28%) and sap (12.12%). The Relative Frequency of Citation was highest for Adina eurhyncha (0.20) and ICF was high across disease categories (0.73-0.97), indicating strong agreement among informants. Index of Cultural Significance values (medicinal use domain) ranged from 6 to 30 and were highest for Senna alata (L.) Roxb. (30). The study provides a reproducible, internally consistent baseline of SAD ethnomedicinal knowledge for future ethnobotanica, pharmacological and conservation research; they do not constitute evidence of clinical efficacy, safety or harvesting sustainability.
No takes yet. Share an insight, caveat, or question.
Asra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: